These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32360116)

  • 1. Aspirin to Reduce Risk for Sudden Cardiac Death in Athletes With Elevated C-Reactive Protein Levels.
    Siegel AJ
    Am J Med; 2020 Sep; 133(9):1014-1016. PubMed ID: 32360116
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin to Prevent Sudden Cardiac Death in Athletes with High Coronary Artery Calcium Scores.
    Siegel AJ; Noakes TD
    Am J Med; 2019 Feb; 132(2):138-141. PubMed ID: 30296406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antithrombotic prevention and therapy in coronary heart disease].
    Bode C; Kohler B; Moser M; Zimmermann R; Strasser RH; Kübler W
    Internist (Berl); 1997 Jul; 38(7):658-66. PubMed ID: 9333599
    [No Abstract]   [Full Text] [Related]  

  • 4. Can pre-race aspirin prevent sudden cardiac death during marathons?
    Siegel AJ; Noakes TD
    Br J Sports Med; 2017 Nov; 51(22):1579-1581. PubMed ID: 28724717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2008; 80(12):89-95. PubMed ID: 19227916
    [No Abstract]   [Full Text] [Related]  

  • 6. Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
    Lopes RD; Leonardi S; Wojdyla DM; Vora AN; Thomas L; Storey RF; Vinereanu D; Granger CB; Goodman SG; Aronson R; Windecker S; Thiele H; Valgimigli M; Mehran R; Alexander JH
    Circulation; 2020 Mar; 141(9):781-783. PubMed ID: 31707833
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study.
    Mehran R; Aymong ED; Ashby DT; Fischell T; Whitworth H; Siegel R; Thomas W; Wong SC; Narasimaiah R; Lansky AJ; Leon MB
    Circulation; 2003 Sep; 108(9):1078-83. PubMed ID: 12925457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of ticlopidine and clopidogrel in comparison with acetylsalicylic acid].
    Weber AA; Schrör K
    Internist (Berl); 1997 Nov; 38(11):1115-20; discussion 1120. PubMed ID: 9453968
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic agents in coronary artery disease.
    Cairns JA; Théroux P; Lewis HD; Ezekowitz M; Meade TW; Sutton GC
    Chest; 1998 Nov; 114(5 Suppl):611S-633S. PubMed ID: 9822067
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.
    Silber S; Kirtane AJ; Belardi JA; Liu M; Brar S; Rothman M; Windecker S
    Eur Heart J; 2014 Aug; 35(29):1949-56. PubMed ID: 24510638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiplatelet agents--problem for cardiac surgeon].
    Bochenek A; Wilczyński M
    Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin resistance following pediatric cardiac surgery.
    Cholette JM; Mamikonian L; Alfieris GM; Blumberg N; Lerner NB
    Thromb Res; 2010 Sep; 126(3):200-6. PubMed ID: 20550971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death in ischemic heart disease.
    Chang D; Goldstein S
    Compr Ther; 1997 Feb; 23(2):95-103. PubMed ID: 9083719
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombin generation in myocardial infarction and hypercholesterolemia: effects of aspirin.
    Szczeklik A
    Thromb Haemost; 1995 Jul; 74(1):77-80. PubMed ID: 8578530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease.
    O'Brien M; Parness IA; Neufeld EJ; Baker AL; Sundel RP; Newburger JW
    Pediatrics; 2000 May; 105(5):E64. PubMed ID: 10799628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary stenting (Cordis) without anticoagulation.
    Park SW; Park SJ; Hong MK; Kim JJ; Cho SY; Jang YS; Kim KB; Kim KS; Oh DJ; Oh BH; Kang JC
    Am J Cardiol; 1997 Apr; 79(7):901-4. PubMed ID: 9104903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial.
    Schühlen H; Hadamitzky M; Walter H; Ulm K; Schömig A
    Circulation; 1997 Apr; 95(8):2015-21. PubMed ID: 9133509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-eluting stent thrombosis and its pharmacological prevention].
    Pershukov IV; Batyraliev TA
    Kardiologiia; 2007; 47(7):60-7. PubMed ID: 18260897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel is more effective than aspirin as adjuvant treatment to prevent reocclusion after thrombolysis.
    Yao SK; Ober JC; Ferguson JJ; Maffrand JP; Anderson HV; Buja LM; Willerson JT
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H488-93. PubMed ID: 8067400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sudden cardiac death in athletes].
    Mijailović ZM; Stajić Z; Tavciovski D; Matunović R
    Med Pregl; 2009; 62(1-2):37-41. PubMed ID: 19514599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.